Market Tracker

03/31 8:21am ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.38
Delayed Data
As of Mar 30
 -0.16 / -2.45%
Today’s Change
3.71
Today|||52-Week Range
14.80
+39.91%
Year-to-Date

Today’s Trading

Previous close6.54
Today’s open6.55
Day’s range6.25 - 6.56
Volume237,616
Average volume (3 months)209,825
Market cap$69.1M
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.08-0.88%
AVEOAveo Pharmaceuticals...+0.07+5.11%
CRBPCorbus Pharmaceutica...+0.11+3.97%
ADMPAdamis Pharmaceutica...-1.56-28.94%
Data as of 03/30/2015

Financials

Last reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts